Dr. Shankar Alegaon View Publications

Shankar Alegaon

Dr. Shankar Alegaon

Professor & Head, Dept. of Pharmaceutical Chemistry

+91 831 2471399
9480397673
Department of Pharmaceutical Chemistry KLE College of Pharmacy, Karnataka, Belagavi, Karnataka, India - 590 010

Experience and Background


Graduation B.Pharm
Specialization Pharmacy
Post Graduation M.Pharm
Specialization Pharmaceutical chemistry
PhD and Others Ph.D
Specialization Pharmaceutical chemistry
Teaching Experience(Total Years) 18
Research Experience(Total Years) 15
Industry Experience(Total Years) None
Teaching (Graduate level) Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Analysis
Teaching (Post-Graduate level) Modern Pharmaceutical Analysis, Advanced Spectral Analysis and CADD
Projects Carried 16
Total Papers published 22
Patents -
Total Papers Presented 12

Publications


1. Synthesis, characterization and antimicrobial activity evaluation of new 2,4-Thiazolidinediones bearing imidazo[2,1-b][1,3,4]thiadiazole moiety

2. Microwave-Assisted Synthesis, Antimicrobial and Cytotoxic Activities of Some 4-Thioxo-Thiazolidine-2-One Derivatives

3. New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties

4. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents

5. New thiazolidine-2,4-diones as antimicrobial and cytotoxic agent

6. Synthesis, characterization, and biological evaluation of thiazolidine-2,4-dione derivatives

7. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives

8. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents

9. Synthesis, pharmacophore modeling, and cytotoxic activity of 2-thioxothiazolidin-4- one derivatives

10. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors

11. Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines

12. Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors

13. Synthesis and biological evaluation of 1,3,4-trisubstituted pyrazole analogues as anti-mycobacterial agents

14. Synthesis of new 7-chloro-4-phenoxyquinoline analogues as potential antitubercular agents

15. Synthesis and biological evaluation of some 4-aminoquinoline derivatives as potential antitubercular agents

16. Design and synthesis of new 3-((7- chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors

17. Synthesis, molecular docking and ADME studies of thiazole-thiazolidinedione hybrids as antimicrobial agents

18. Shankar G Alegaon_CV_2023

19. Shankar G Alegaon_CV_2023